Is There Value in Repeating Inhaled Nitric Oxide Vasoreactivity Tests in Patients with Pulmonary Arterial Hypertension?

被引：0
作者：
Rubabin Tooba
Allaa Almoushref
Adriano R. Tonelli
机构：
[1] Cleveland Clinic,Department of Internal Medicine
[2] Cleveland Clinic,Division of Immunity and Inflammation, Lerner Institute
[3] Cleveland Clinic,Department of Pulmonary, Allergy and Critical Care Medicine, Respiratory Institute
[4] Cleveland Clinic,Pathobiology Division, Lerner Research Institute
来源：
Lung | 2020年 / 198卷
关键词：
Inhaled nitric oxide; Pulmonary arterial hypertension; Pulmonary vasoreactivity test; Pulmonary hypertension; Right heart catheterization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 94
页数：7
相关论文
共 144 条
[1]  
Tonelli AR(2013)Causes and circumstances of death in pulmonary arterial hypertension Am J Respir Crit Care Med 188 365-369
[2]  
Arelli V(2019)Haemodynamic definitions and updated clinical classification of pulmonary hypertension Eur Respir J 53 1801913-975
[3]  
Minai OA(2015)2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Respir J 46 903-496
[4]  
Newman J(2010)Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension Respir Med 104 481-270
[5]  
Bair N(1998)Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension Eur Respir J 12 265-119
[6]  
Heresi GA(2016)2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J 37 67-3111
[7]  
Simonneau G(2005)Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 3105-271
[8]  
Montani D(2011)Response to inhaled nitric oxide predicts survival in patients with pulmonary hypertension J Card Fail 17 265-234
[9]  
Celermajer DS(2004)Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension Respir Med 98 225-62S
[10]  
Denton CP(2004)Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 35S-1928
12345678910